BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
Ikonen
T
T
Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Finland. tarja.ikonen@uta.fi
Matikainen
M P
MP
Syrjäkoski
K
K
Mononen
N
N
Koivisto
P A
PA
Rökman
A
A
Seppälä
E H
EH
Kallioniemi
O-P
OP
Tammela
T L J
TL
Schleutker
J
J
D000368:Aged; D000369:Aged, 80 and over; D019313:BRCA1 Protein / Q000235:genetics* / Q000502:physiology; D024682:BRCA2 Protein / Q000235:genetics* / Q000502:physiology; D005387:Finland; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000235:genetics*
D019313:BRCA1 Protein; D024682:BRCA2 Protein